China News Service, September 16 According to a report by South American Overseas Chinese News on the 15th, recently, the Colombian National Food and Drug Administration began recruiting volunteers to prepare for the third phase of clinical trials of the new crown vaccine.
According to reports, the department issued a statement stating that Colombia is one of the first countries in Latin America to start clinical trials of the new crown vaccine. The clinical trials will conduct trials and evaluations on the safety and specific efficacy of the new crown vaccine to ensure that the vaccine can be widely used.
According to the report, the statement emphasized, "On September 10, we received the results of the first and second phases of the new crown vaccine clinical trial. The results show that Colombia now has the conditions to start the third phase of clinical trials. The third phase of the trial is expected to start at 9. Officially started on the 21st."
According to reports, the Phase III clinical trial needs to record relevant data of different injection doses after each administration, including the subject's reactogenicity and adverse symptoms.
It is said that four research institutions have been authorized to conduct Phase III clinical trials, located in Barranquilla, Medellin and Bogotá.
However, to ensure the health and safety of volunteers, this clinical trial may be interrupted at any time.